Form 4: Braze Inc. Executive Myles Kleeger Executes Stock Option, Sells Shares
SEC Form 4
Myles Kleeger, President & CCO of Braze Inc., exercised stock options and sold shares of Class A Common Stock on August 26, 2024, according to a Form 4 filing with the SEC.
Summary
- Myles Kleeger, the President & CCO of Braze, Inc., engaged in transactions involving the company's stock on August 26, 2024.
- Kleeger exercised a stock option to acquire 50,000 shares of Class B Common Stock, which were then converted into Class A Common Stock.
- He sold 46,311 shares of Class A Common Stock at a weighted average price of $45.62 and 3,689 shares at a weighted average price of $46.04.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 29, 2023.
- Following these transactions, Kleeger directly owns 199,963 shares of Class A Common Stock and holds derivative securities representing rights to acquire additional shares.
- Kleeger also has indirect beneficial ownership of shares held in a family trust and a family GRAT.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. The transactions appear to be part of a pre-planned strategy, so there's no indication of positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to sell shares over time.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with shareholders'.
- Rule 10b5-1 trading plans are a standard practice among corporate executives to avoid accusations of insider trading.
- The size and frequency of these transactions are typical for executives at publicly traded companies like Braze, comparable to similar filings from executives at companies like Salesforce (CRM) or Adobe (ADBE).
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the increased supply of shares in the market.
- The transactions do not appear to have any impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| December 29, 2023 | Date of adoption of Rule 10b5-1 trading plan |
| August 26, 2024 | Date of stock option exercise and stock sales |
| August 28, 2024 | Date of Form 4 filing |
| February 14, 2028 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.